Definition of Dacetuzumab. Meaning of Dacetuzumab. Synonyms of Dacetuzumab

Here you will find one or more explanations in English for the word Dacetuzumab. Also in the bottom left of the page several parts of wikipedia pages related to the word Dacetuzumab and, of course, Dacetuzumab synonyms and on the right images related to the word Dacetuzumab.

Definition of Dacetuzumab

No result for Dacetuzumab. Showing similar results...

Meaning of Dacetuzumab from wikipedia

- Dacetuzumab (also known as SGN-40 or huS2C6) is a humanized monoclonal antibody being developed for the treatment of CD40-positive cancers like non-Hodgkin's...
- Ardenermin Dulanermin Antibodies: Belimumab Brentuximab vedotin Conatumumab Dacetuzumab Denosumab Drozitumab Enavatuzumab Iratumumab Lexatumumab Lucatumumab...
- Corporate Press Release Seattle Genetics Announces Discontinuation of Dacetuzumab Phase IIb Diffuse Large B-Cell Lymphoma Clinical TrialCorporate Press...
- dabrafenib (INN) dabuzalgron (USAN) dacarbazine (INN) dacemazine (INN) dacetuzumab (USAN, INN) dacisteine (INN) daclizumab (INN) dacopafant (INN) dactinomycin...
- Ardenermin Dulanermin Antibodies: Belimumab Brentuximab vedotin Conatumumab Dacetuzumab Denosumab Drozitumab Enavatuzumab Iratumumab Lexatumumab Lucatumumab...
- infectious disease/influenza A Cusatuzumab mab humanized CD70 cancer Dacetuzumab mab humanized CD40 hematologic cancers Daclizumab Zenapax mab humanized...
- Ardenermin Dulanermin Antibodies: Belimumab Brentuximab vedotin Conatumumab Dacetuzumab Denosumab Drozitumab Enavatuzumab Iratumumab Lexatumumab Lucatumumab...
- Ardenermin Dulanermin Antibodies: Belimumab Brentuximab vedotin Conatumumab Dacetuzumab Denosumab Drozitumab Enavatuzumab Iratumumab Lexatumumab Lucatumumab...
- Ardenermin Dulanermin Antibodies: Belimumab Brentuximab vedotin Conatumumab Dacetuzumab Denosumab Drozitumab Enavatuzumab Iratumumab Lexatumumab Lucatumumab...
- Ardenermin Dulanermin Antibodies: Belimumab Brentuximab vedotin Conatumumab Dacetuzumab Denosumab Drozitumab Enavatuzumab Iratumumab Lexatumumab Lucatumumab...